scholarly journals Differences in health care outcomes between postdischarge COPD patients treated with inhaled corticosteroid/long-acting β2-agonist via dry-powder inhalers and pressurized metered-dose inhalers

2018 ◽  
Vol Volume 14 ◽  
pp. 101-114
Author(s):  
Eric T Wittbrodt ◽  
Lauren A Millette ◽  
Kristin A Evans ◽  
Machaon Bonafede ◽  
Joseph Tkacz ◽  
...  
Keyword(s):  
Health Care ◽  
Dry Powder Inhalers ◽  
Inhaled Corticosteroid ◽  
Metered Dose Inhalers ◽  
Dry Powder ◽  
Health Care Outcomes ◽  
Copd Patients ◽  
Metered Dose ◽  
Care Outcomes ◽  
Long Acting

scholarly journals Medication Administration With Inhalers or Nebulizers

2021 ◽  
Vol 1 (11) ◽  
Author(s):  
Khai Than ◽  
Aleksandra Grobelna
Keyword(s):  
Clinical Effectiveness ◽  
Medication Administration ◽  
Chronic Obstructive ◽  
Dry Powder Inhalers ◽  
Metered Dose Inhalers ◽  
Dry Powder ◽  
Obstructive Pulmonary Disease ◽  
Metered Dose ◽  
The Cost ◽  
Evidence Based Guidelines

Delivery of medication via metered-dose inhalers to children or adults with asthma, or adults with chronic obstructive pulmonary disease at emergency departments or intensive care units, may be as effective as nebulizers in terms of clinical parameters and health care resource use. Limited data on adverse events showed no significant differences between metered-dose inhalers and nebulizers. No evidence was found on the clinical effectiveness of dry powder inhalers in comparison with nebulizers or metered-dose inhalers. No evidence was found on the cost-effectiveness of medication administration via metered-dose inhalers, nebulizers, or dry powder inhalers in comparison with each other. No evidence-based guidelines with recommendations regarding the comparative use of metered-dose inhalers, dry powder inhalers, or nebulizers for administration of medication were identified.

Equivalence testing and equivalence limits of metered-dose inhalers and dry powder inhalers measured by in vitro impaction

2000 ◽  
Vol 49 (3) ◽  
pp. 295-302 ◽  
Author(s):  
Marjolein Weda ◽  
Eduard R.M Geuns ◽  
Raymond C.R Vermeer ◽  
Nathalie R.A Buiten ◽  
Kirsten Hendriks-de Jong ◽  
...  
Keyword(s):  
Dry Powder Inhalers ◽  
Equivalence Testing ◽  
Metered Dose Inhalers ◽  
Dry Powder ◽  
Metered Dose

Dry Powder Inhalers Are Bioequivalent to Metered-Dose Inhalers

CHEST Journal ◽  
1995 ◽  
Vol 107 (3) ◽  
pp. 629-633 ◽  
Author(s):  
Michael Hindle ◽  
Duncan A.G. Newton ◽  
Henry Chrystyn
Keyword(s):  
Dry Powder Inhalers ◽  
Metered Dose Inhalers ◽  
Dry Powder ◽  
Metered Dose

Inhaled therapy for asthma

2020 ◽  
Vol 31 (7) ◽  
pp. 290-299
Author(s):  
Andrew Booth
Keyword(s):  
Asthma Control ◽  
Asthma Management ◽  
Dry Powder Inhalers ◽  
Asthma Treatment ◽  
Metered Dose Inhalers ◽  
National Guidelines ◽  
Inhaled Therapy ◽  
Daily Dose ◽  
Metered Dose ◽  
Long Acting

Andrew Booth explains why this is the preferred − and more successful − method when managing asthma Inhaled therapy is key to the successful treatment of asthma. National guidelines provide us with the aim of asthma management, which is to maintain control of the disease. The correct combination of drug and device can be individually tailored to the patient. Drugs consist of bronchodilators and anti-inflammatories. Devices consist of aerosol inhalers, also known as pressurised metered dose inhalers, and dry powder inhalers. Both the drug and the device need to be prescribed if the treatment is to be clinically effective. A combination of inhaled steroid with long-acting B2 agonist is one of the most clinically effective ways of delivering asthma treatment. This can be prescribed either as a fixed daily dose with a concomitant short-acting B2 agonist as a reliever, or as maintenance and reliever therapy, which has been shown to improve asthma control and reduce exacerbations.

Sign in / Sign up

Export Citation Format

Share Document